Abstract
Background: The management of pleural neoplasms, specifically mesothelioma, remains difficult. We performed a phase I trial in 54 patients with isolated hemithorax pleural malignancy to determine (a) the feasibility of intraoperative, intrapleural photodynamic therapy after debulking surgery; (b) the influence of light dose/sensitizer interval on postoperative morbidity in order to define the photodynamic therapy (PDT) maximal tolerated dose (MTD); and (c) whether first order dosimetry could be applied to this complex geometry.
Methods: Cohorts of three patients were given escalating intraoperative light doses of 15–35 J/cm2 48 h after i.v. delivery of 2.0 mg/kg Photofrin II (Quadra Logic Technologies, Vancouver, British Columbia, Canada), and then escalating light doses of 30–32.5 J/cm2 after a 24-h sensitizer/operation interval. Twelve patients could not be debulked to the prerequisite 5 mm residual tumor thickness. The remaining 42 patients underwent 19 modified pleuropneumonectomies, five lobectomy-pleurectomies, and 18 pleurectomies. Intrapleural PDT was delivered using 630 nm light from two argon pump-dye lasers, and real-time and cumulative light doses were monitored using seven uniquely designed, computer-interfaced photodiodes.
Results: There was one 30-day mortality from intraoperative hemorrhage. In the 48-h sensitizer/operation group (n=33), possible PDT-related complications included an empyema with late hemorrhage in one of three patients at 17.5 J/cm2 and a bronchopleural fistula at 35 J/cm2. At each of these light doses, three additional patients were treated without complication. Two patients subjected to 24-h sensitizer dosing and 32.5 J/cm2 developed esophageal perforations after pleuropneumonectomy at identical sites. The MTD was declared as 30 J/cm2 light with a 24-h dosing interval when none of the six patients (three original, three repeat) at that level developed toxicity.
Conclusions: These data demonstrate that resection and intrapleural PDT can be performed safely with currently available sensitizers and lasers. Phase II and III trials are now warranted at this MTD in a homogeneous population of patients with pleural malignancies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Newhouse M. Epidemiology of asbestos-related tumors.Semin Oncol 1981;8:250–7.
Nicholson NJ, Perkel G, Selikoff IJ. Occupational exposure to asbestos: population at risk and projected mortality, 1980–2030.Am J Ind Med 1982;3:259–311.
Antman KH, Pass HI, Recht A. Benign and malignant mesothelioma. In: DeVita V, Hellman S, Rosenberg SA, eds.Cancer: principles and practice of oncology. Philadelphia, PA: JB Lippincott, 1989:1399–417.
Hilaris BS, Dattatreyudu N, Kwong E, Kutcher GJ, Martini N. Pleurectomy and intraoperative brachytherapy and post-operative radiation in the management of malignant pleural mesothelioma.Int J Radiat Oncol Biol Phys 1984;10:325–31.
Pass HI. Malignant pleural and pericardial effusions in cancer. In: Devita V, Hellman S, Rosenberg SA, eds.Principles and practice of oncology. Philadelphia, PA: JB Lippincott, 1989:2449–59.
Russo A, Mitchell JB, Pass HI, Glatstein E. Photodynamic therapy. In: Devita V, Hellman S, Rosenberg SA, eds.Cancer: Principles and practice of oncology. Philadelphia, PA: JB Lippincott, 1989:2449–59.
DeLaney TF, Smith PD, Thomas GF, et al. A light-diffusing device for intraoperative photodynamic therapy in the peritoneal or pleural cavity.J Clin Laser Med Surg Oct 1991;361–6.
Perry RR, Matthews W, Pass HI, et al. Sensitivity of different human lung cancer histologies to photodynamic therapy.Cancer Res 1990;50:4272–6.
Perry RR, Evans S, Matthews W, Rizzoni W, Russo A, Pass HI. Potentiation of phototherapy cytotoxicity with light scattering media.J Surg Res 1989;46:386–90.
Friauf WS, Smith PE, Russo A, et al. Light monitoring in photo-dynamic therapy. In: Nagle HT, Tompkins WJ, eds.Case studies in medical instrument design. New York: The Institute of Electrical and Electronics Engineers, 1992:127–38.
Pass HI, Delaney T. Innovative photodynamic therapy at the National Cancer Institute: intraoperative, intracavitary treatment. In: Henderson BW, Dougherty TJ, eds.Photodynamic therapy: basic principles and clinical applications. New York: Marcel Dekker, 1992:287–301.
Pass HI, Delaney T, Russo A, et al. Feasibility of intrapleural photodynamic therapy: the first eight patients. Proceedings of optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy.SPIE 1992;1645:2–9.
Sindelar WF, DeLaney TF, Tochner Z, et al. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms.Arch Surg 1991;126:318–24.
Pelton JJ, Kowalyshyn MJ, Keller SM. Intrathoracic organ injury associated with photodynamic therapy.J Thorac Cardiovasc Surg 1992;103:1218–23.
Author information
Authors and Affiliations
Additional information
Work of the US government. Not subject to copyright in the United States.
Rights and permissions
About this article
Cite this article
Pass, H.I., DeLaney, T.F., Tochner, Z. et al. Intrapleural photodynamic therapy: Results of a phase I trial. Annals of Surgical Oncology 1, 28–37 (1994). https://doi.org/10.1007/BF02303538
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02303538